Diaceutics (DXRX) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Mar 2023 01:57 PM
RNS
PDMR Shareholding/Share Incentive Plan
30 Jan 2023 05:11 PM
RNS
PDMR Shareholding/Share Incentive Plan
26 Jan 2023 07:00 AM
RNS
USD 7m enterprise engagements for data services
26 Jan 2023 07:00 AM
RNS
Trading Statement and Strategy Update
03 Jan 2023 07:00 AM
RNS
PDMR Shareholding/Share Incentive Plan
29 Nov 2022 07:00 AM
RNS
Change of Auditor
29 Nov 2022 07:00 AM
RNS
PDMR Shareholding/Share Incentive Plan
01 Nov 2022 07:00 AM
RNS
Sub-optimal testing impacts on cancer patients
31 Oct 2022 02:20 PM
RNS
PDMR Shareholding/Share Incentive Plan
05 Oct 2022 05:03 PM
RNS
PDMR Shareholding/Share Incentive Plan
05 Oct 2022 07:00 AM
RNS
Purchase of Shares and PDMR Shareholding
27 Sep 2022 07:00 AM
RNS
Half-year Report
12 Sep 2022 12:38 PM
RNS
PDMR Shareholding/Share Incentive Plan
08 Sep 2022 07:00 AM
RNS
Notice of Results and Presentations
08 Aug 2022 07:00 AM
RNS
PDMR Shareholding/Share Incentive Plan
26 Jul 2022 07:00 AM
RNS
Trading Update and Notice of Results
22 Jul 2022 05:45 PM
RNS
PDMR Shareholding/Share Incentive Plan
13 Jun 2022 07:00 AM
RNS
Multi-year contract with top five global pharma
07 Jun 2022 07:00 AM
RNS
New AI and ML Capabilities Enhance DXRX Platform
31 May 2022 12:12 PM
RNS
PDMR Shareholding/Share Incentive Plan
27 May 2022 04:31 PM
RNS
Share Options and PDMR Shareholdings
26 May 2022 03:00 PM
RNS
Result of AGM
11 May 2022 02:34 PM
RNS
PDMR Shareholding/Share Incentive Plan
09 May 2022 04:37 PM
RNS
Exercise of Warrant & Total Voting Rights
05 May 2022 07:00 AM
RNS
Contract Win
29 Apr 2022 05:22 PM
RNS
PDMR Shareholding/Share Incentive Plan
28 Apr 2022 02:09 PM
RNS
Notice of AGM and Posting of Annual Report
07 Apr 2022 07:00 AM
RNS
Purchase and Sale of Shares and PDMR Shareholdings
06 Apr 2022 01:13 PM
RNS
PDMR Shareholding/Share Incentive Plan
05 Apr 2022 03:49 PM
RNS
Conversion of Convertible Loan Notes & TVR
01 Apr 2022 07:00 AM
RNS
Issue of Share Options / PDMR Shareholdings
31 Mar 2022 05:38 PM
RNS
PDMR Shareholding/Share Incentive Plan
22 Mar 2022 02:43 PM
RNS
Final Results
22 Mar 2022 07:00 AM
RNS
Notice of 2021 Full Year Results
18 Mar 2022 02:09 PM
RNS
Confirmation of Directorate Change
16 Mar 2022 05:49 PM
RNS
Holding(s) in Company
16 Mar 2022 07:00 AM
RNS
Approval by CMS for enhanced data access
02 Mar 2022 05:37 PM
RNS
PDMR Shareholding/Share Incentive Plan
21 Feb 2022 07:00 AM
RNS
Investor Presentation
14 Feb 2022 06:26 PM
RNS
PDMR Shareholding/Share Incentive Plan
14 Feb 2022 07:00 AM
RNS
Contract with leading life sciences company
04 Feb 2022 11:26 AM
RNS
Director/PDMR Shareholding
11 Jan 2022 07:01 AM
RNS
Directorate Change
11 Jan 2022 07:00 AM
RNS
Trading Update and Notice of Results
04 Jan 2022 07:00 AM
RNS
PDMR Shareholding/Share Incentive Plan
14 Dec 2021 07:00 AM
RNS
Contract Win
09 Dec 2021 07:00 AM
RNS
Test Signal Launch and Contract Wins
01 Dec 2021 05:22 PM
RNS
PDMR Shareholding/Share Incentive Plan
09 Nov 2021 04:57 PM
RNS
PDMR Shareholding/Share Incentive Plan
01 Oct 2021 01:19 PM
RNS
PDMR Shareholding/Share Incentive Plan

Diaceutics is a technology and data analytics company focused on precision medicine. Headquartered in Belfast, the company provides data, software, and advisory services that help pharmaceutical and biotechnology companies improve the adoption of diagnostic testing and support the commercialisation of precision therapies. Its platform integrates real-world diagnostic data from a global network of laboratories to provide insights into testing and treatment pathways.

Diaceutics share price is listed in London under the ticker DXRX.

UK 100